The Gerson Institute - Alternative Cancer Treatment

Links shared publicly online about this topic.

  • 1,255
    total visits

The Gerson Institute - Alternative Cancer Treatment

gerson.org

The Gerson Institute is dedicated to healing cancer and preventing chronic and degenerative diseases (cancer, diabetes, hepatitis and more) based on the vision, philosophy and successful work of Max Gerson, MD.

View full resource at gerson.org

Tags: Pancreatic Disease, Cancer, Pancreatic Cancer, Parenting, Preventing, Education

  • Share

Most Recently Shared on April 8, 2010 at 3:31 pm By:

jxa0 John Amschler

Dad is educating himself about healing options by talking w a #Pancreatic #Cancer Survivor who used the #Gerson method. http://ow.ly/1w4VV

2 years ago...

Identifying A Molecular-Based Treatment For A Viral Skin Cancer

medicalnewstoday.com — “Four years after they discovered the viral roots of a rare skin cancer, researchers at the University of Pittsburgh Cancer Institute (UPCI) and the School of Medicine have now identified a moleculView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 11, 2012 at 7:05 am By:

mnt_diseases MNT Infect Diseases Health News

Identifying A Molecular-Based Treatment For A Viral Skin Cancer http://t.co/reDzqgWe #viruses #bacteria

3 weeks ago...

PDE4 enzyme regulates division of tumour cells and blood vessel growth in cancer tissue

news-medical.net — “Lung cancer is the leading cause of cancer death throughout the world. Standard treatment methods do not usually result in long-term recovery. In addition to the proliferation of the tumour cells, the growth of blood vessels controls tumors development. The blood vessel growth is controlled by several signalling molecules. Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim and Justus Liebig University Giessen have discovered a molecule that plays a key role in thView full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 5, 2012 at 12:37 pm By:

Oncology_News News-Medical.Net Health News and Oncology

Oncology News: PDE4 enzyme regulates division of tumour cells and blood vessel growth in cancer tissue: Lung can... http://t.co/2fLg0VAG

4 weeks ago...

New genetic pathway influences spread of cancer cells

news-medical.net — “In a new study from Lawson Health Research Institute, Dr. Joseph Torchia has identified a new genetic pathway influencing the spread of cancer cells. The discovery of this mechanism could lead to new avenues for treatment.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 12:33 pm By:

Oncology_News News-Medical.Net Health News and Oncology

Oncology News: New genetic pathway influences spread of cancer cells: In a new study from Lawson Health Research... http://t.co/DyCRCHSb

4 weeks ago...

Hormone-receptor-positive cancer management study - National Cancer Institute

cancer.gov — “American and Spanish researchers, led by scientists from the University of North Carolina, Chapel Hill, have found potential ways for doctors to improve the treatment of hormone receptor-positive breast cancer even if they lack access to costly multi-geneView full resource at cancer.gov

  • View Related
  • Share

Most Recently Shared on May 3, 2012 at 11:00 pm By:

NCIMedia NCI Media Relations

Study led by @UNC_Lineberger measures progesterone receptor expression 2 improve hormone-receptor-pos #cancer mgmnt http://t.co/vTp80jLP

1 month ago...

New findings at European breast cancer conference - National Cancer Institute

cancer.gov — “An experimental model of breast cancer has yielded exciting new insights into why some breast cancers become resistant to endocrine therapies such as tamoxifen, say researchers from the Hospital of Prato, Italy, and the Breast Center at Baylor College ofView full resource at cancer.gov

  • View Related
  • Share

Most Recently Shared on May 3, 2012 at 9:30 pm By:

Pitt study of ultrasound-guided axillary node biopsy - National Cancer Institute

cancer.gov — “Contrary to a trend in treatment, breast cancer patients with suspicious lymph nodes should have an ultrasound-guided axillary node biopsy, and if that biopsy is positive these patients should undergo an axillary dissection, a new study shows. The study,View full resource at cancer.gov

  • View Related
  • Share

Most Recently Shared on May 3, 2012 at 9:00 pm By:

NCIMedia NCI Media Relations

Study by #PITT finds #breast #cancer patients w/ positive ultrasound guided axillary node biopsy need dissection http://t.co/QboQ3tO7

1 month ago...

Combination of new prostate cancer drugs can extend life for men

news-medical.net — “Combing two new prostate cancer drugs could increase the number of men who respond to treatment and the length of time they benefit, research led by The Institute of Cancer Research (ICR) has shown.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 2, 2012 at 10:07 am By:

Cancer_PC Prostate Cancer OW OW Health

Combination of new prostate cancer drugs can extend life for men: Combing two new prostate cancer drugs could in... http://t.co/ZXZktfuC

1 month ago...

New form and function of a key protein - National Cancer Institute

cancer.gov — “Research led by St. Jude Children’s Research Hospital investigators suggests that safeguarding cell survival and maintaining a balanced immune system is just the start of the myeloid cell leukemia sequence 1 (MCL1) protein’s work. Nearly 20 years after MCView full resource at cancer.gov

  • View Related
  • Share

Most Recently Shared on May 1, 2012 at 7:36 pm By:

NCIMedia NCI Media Relations

Scientists at @StJude discover new form & function of a key protein that may provide a novel #cancer treatment target http://t.co/22W3HOTY

1 month ago...

Found in Translation: Finding Better Cancer Therapies -- Faster - DukeHealth.org

dukehealth.org — “With a bold strategy to spark innovative ideas and bring them into practice, Duke Cancer Institute is finding ways to bring new cancer therapies to patients faster.View full resource at dukehealth.org

  • View Related
  • Share

Most Recently Shared on April 23, 2012 at 5:40 pm By:

Duke_Medicine Duke Medicine Hospital

Duke's translational research program helps to bring cancer treatments from the lab to the clinic http://t.co/HvuOheaH

1 month ago...

Dr. Dunleavy Discusses Treatment Options for PMBL

onclive.com — “Dr. Kieron Dunleavy, from the National Cancer Institute, Discusses Treatment Options for Primary Mediastinal B Cell LymphomaView full resource at onclive.com

  • View Related
  • Share

Most Recently Shared on April 16, 2012 at 4:47 pm By:

ONClive Editor Oncology

Dr. Kieron Dunleavy, from the National Cancer Institute, Discusses Treatment Options for PMBL http://t.co/MhbpZoBG #OncLiveTV

2 months ago...

Eisai breast cancer drug still viewed as not cost effective by NICE - Pharmaceutical and Biotechnology News - Pharma Letter

thepharmaletter.com — “In a third rejection, the UK drug watchdog the National Institute for Health and clinical Excellence (NICE) has issued new guidance not recommending Halaven (eribulin), from Japanese drug major Eisai (TYO: 4523), for the treatment of locally advanced or mView full resource at thepharmaletter.com

  • View Related
  • Share

Most Recently Shared on April 3, 2012 at 12:13 pm By:

FiercePharma FiercePharma Health Site

Even w/discount MT @ThePharmaLetter: NICE still views Eisai breast cancer drug Halaven as not cost effective http://t.co/Bkd28AWx #pharma

2 months ago...

Investigational targeted drug induces responses in aggressive lymphomas, April 2, 2012 News Release - National Institutes of Health (NIH)

nih.gov — “Preliminary results from clinical trials in a subtype of lymphoma show that for a number of patients whose disease was not cured by other treatments, the drug ibrutinib can provide significant anti-cancer responses with modest side effects. These results were presented as part of the opening plenary session at the American Association of Cancer Research (AACR) Annual Meeting 2012 on April 1 by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, and collView full resource at nih.gov

  • View Related
  • Share

Most Recently Shared on April 2, 2012 at 1:16 pm By:

NIHforHealth NIH for Health

News: Investigational targeted drug induces responses in aggressive lymphomas http://t.co/k15ySoFZ

2 months ago...

Treating Cancer as a Chronic Disease

newswise.com — “New research from the Technion-Israel Institute of Technology and the Rambam Medical Center could someday lead to treatments that transform cancer from a lethal disease to a chronic, manageable one, similar to AIDS.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on March 29, 2012 at 9:57 pm By:

Treating Cancer as a Chronic Disease

newswise.com — “New research from the Technion-Israel Institute of Technology and the Rambam Medical Center could someday lead to treatments that transform cancer from a lethal disease to a chronic, manageable one, similar to AIDS.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on March 29, 2012 at 9:33 pm By:

Treating Cancer as a Chronic Disease

newswise.com — “New research from the Technion-Israel Institute of Technology and the Rambam Medical Center could someday lead to treatments that transform cancer from a lethal disease to a chronic, manageable one, similar to AIDS.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on March 29, 2012 at 8:55 pm By:

mednewswise Thom Canalichio Health News

Treating Cancer as a Chronic Disease: New research from the Technion-Israel Institute of Technology and ... http://t.co/I23wIPgp #cancer

2 months ago...

Advertisement